LEI: 213800DQGNQE3X76WS92
2 December 2024
BREEDON GROUP plc
(the Company or Breedon)
Notification of transactions by Directors/ Persons Discharging Managerial Responsibilities (PDMR) and Persons Closely Associated with them (PCA)
The Company has been notified that, on 27 November 2024, Abicad Holding Limited (Abicad) a PCA of Amit Bhatia, Non-executive Chair of Breedon and a PDMR, had entered into option agreements with a market counterparty under which, if each option is fully exercised, would result in Abicad acquiring 1,500,000 existing ordinary shares of £0.01 each (Shares) in the Company (the Option Agreements).
Should any option(s) be exercised, the Shares acquired under the option(s) would be acquired by Abicad on various dates between 26 August 2025 and 1 December 2025.
The Company understands that these potential acquisitions of ordinary shares by Abicad, and any future acquisitions represent a continuation of Abicad's previously announced intention to make market purchases of shares in the Company over time.
Abicad currently holds 65,554,894 ordinary shares, equating to approximately 19.08 per cent. of the Company's total issued share capital (at today's date). If all of the Shares are acquired under the Option Agreements and Abicad does not dispose of any of its existing interests in ordinary shares, Abicad would have an aggregate interest in 67,054,894 ordinary shares, equating to approximately 19.51 per cent. of the Company's total issued share capital (at today's date).
This notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
Enquiries:
Breedon Group plc www.breedongroup.com
James Atherton-Ham, Group General Counsel 01332 694010
MHP (Public Relations Adviser) 07770 753 544
Reg Hoare
Rachel Farrington
Charles Hirst
Notification and public disclosure of transactions by persons discharging managerial
responsibilities and persons closely associated with them
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||||||||||||||||||||
|
a) |
Name |
Abicad Holding Limited, a person closely associated with Amit Bhatia |
|||||||||||||||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||||||||||||||
|
a) |
Position/status |
Non-executive Chair and PDMR |
|||||||||||||||||||||||||||
|
b) |
Is this an initial notification or an amendment to a prior notification? |
Initial notification |
|||||||||||||||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||||||||||||||
|
a) |
Name |
Breedon Group plc |
|||||||||||||||||||||||||||
|
b) |
LEI |
213800DQGNQE3X76WS92 |
|||||||||||||||||||||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||||||||||||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of £0.01 each
GB00BM8NFJ84 |
|||||||||||||||||||||||||||
|
b) |
Nature of the transaction |
Options to acquire existing Ordinary Shares from a market counterparty, under 3 option agreements |
|||||||||||||||||||||||||||
|
c)
|
Price(s) and volume(s)
|
|
|||||||||||||||||||||||||||
|
d)
|
Aggregated information (if any)
- Aggregated volume
- Price |
1,500,000
£5,752,558.80 |
|||||||||||||||||||||||||||
|
e) |
Date of transaction |
27 November 2024 |
|||||||||||||||||||||||||||
|
f) |
Place of the transaction |
Outside of trading venue |
|||||||||||||||||||||||||||
Notes:
(1) The relevant option tranche is automatically exercised and the relevant Shares are acquired if the closing price of a Breedon ordinary share is below or equal to the relevant exercise price for that tranche on the option expiration date
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
